<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34273510</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>31</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-3511</ISSN><JournalIssue CitedMedium="Internet"><Volume>109</Volume><PubDate><Year>2021</Year><Month>Aug</Month></PubDate></JournalIssue><Title>International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases</Title><ISOAbbreviation>Int J Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Long-term clinical follow-up of patients suffering from moderate-to-severe COVID-19 infection: a monocentric prospective observational cohort study.</ArticleTitle><Pagination><StartPage>209</StartPage><EndPage>216</EndPage><MedlinePgn>209-216</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijid.2021.07.016</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1201-9712(21)00572-5</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Various symptoms and considerable organ dysfunction persist following infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Uncertainty remains about the potential mid- and long-term health sequelae. This prospective study of patients hospitalized with coronavirus disease 2019 (COVID-19) in Li&#xe8;ge University Hospital, Belgium aimed to determine the persistent consequences of COVID-19.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Patients admitted to the University Hospital of Li&#xe8;ge with moderate-to-severe confirmed COVID-19, discharged between 2 March and 1 October 2020, were recruited prospectively. Follow-up at 3 and 6 months after hospital discharge included demographic and clinical data, biological data, pulmonary function tests (PFTs) and high-resolution computed tomography (CT) scans of the chest.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 199 individuals were included in the analysis. Most patients received oxygen supplementation (80.4%). Six months after discharge, 47% and 32% of patients still had exertional dyspnoea and fatigue. PFTs at 3-month follow-up revealed a reduced diffusion capacity of carbon monoxide (mean 71.6 &#xb1; 18.6%), and this increased significantly at 6-month follow-up (P&lt;0.0001). Chest CT scans showed a high prevalence (68.9% of the cohort) of persistent abnormalities, mainly ground glass opacities. Duration of hospitalization, intensive care unit admission and mechanical ventilation were not associated with the persistence of symptoms 3 months after discharge.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The prevalence of persistent symptoms following hospitalization with COVID-19 is high and stable for up to 6 months after discharge. However, biological, functional and iconographic abnormalities improved significantly over time.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Darcis</LastName><ForeName>Gilles</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, University Hospital of Li&#xe8;ge, Li&#xe8;ge, Belgium. Electronic address: gdarcis@chuliege.be.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bouquegneau</LastName><ForeName>Antoine</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Nephrology-Dialysis-Transplantation, University Hospital of Li&#xe8;ge, Li&#xe8;ge, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maes</LastName><ForeName>Nathalie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Medico-Economic Information, University Hospital of Li&#xe8;ge, Li&#xe8;ge, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thys</LastName><ForeName>Marie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Medico-Economic Information, University Hospital of Li&#xe8;ge, Li&#xe8;ge, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henket</LastName><ForeName>Monique</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pneumology, University Hospital of Li&#xe8;ge, Li&#xe8;ge, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Labye</LastName><ForeName>Florence</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University Hospital of Li&#xe8;ge, Li&#xe8;ge, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rousseau</LastName><ForeName>Anne-Fran&#xe7;oise</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, University Hospital of Li&#xe8;ge, Li&#xe8;ge, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Canivet</LastName><ForeName>Perrine</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Radiology, University Hospital of Li&#xe8;ge, Li&#xe8;ge, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Desir</LastName><ForeName>Colin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Radiology, University Hospital of Li&#xe8;ge, Li&#xe8;ge, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calmes</LastName><ForeName>Doriane</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pneumology, University Hospital of Li&#xe8;ge, Li&#xe8;ge, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schils</LastName><ForeName>Raphael</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, University Hospital of Li&#xe8;ge, Li&#xe8;ge, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Worm</LastName><ForeName>Sophie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, University Hospital of Li&#xe8;ge, Li&#xe8;ge, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xe9;onard</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, University Hospital of Li&#xe8;ge, Li&#xe8;ge, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meunier</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Radiology, University Hospital of Li&#xe8;ge, Li&#xe8;ge, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moutschen</LastName><ForeName>Michel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, University Hospital of Li&#xe8;ge, Li&#xe8;ge, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Louis</LastName><ForeName>Renaud</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pneumology, University Hospital of Li&#xe8;ge, Li&#xe8;ge, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guiot</LastName><ForeName>Julien</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pneumology, University Hospital of Li&#xe8;ge, Li&#xe8;ge, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>Int J Infect Dis</MedlineTA><NlmUniqueID>9610933</NlmUniqueID><ISSNLinking>1201-9712</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">post-COVID</Keyword><Keyword MajorTopicYN="N">post-acute COVID-19</Keyword><Keyword MajorTopicYN="N">sequelae</Keyword></KeywordList><CoiStatement>Conflict of interest statement None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>5</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>7</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>17</Day><Hour>20</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>7</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34273510</ArticleId><ArticleId IdType="pmc">PMC8278829</ArticleId><ArticleId IdType="doi">10.1016/j.ijid.2021.07.016</ArticleId><ArticleId IdType="pii">S1201-9712(21)00572-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequalae of COVID-19. Nature. 2021;594:259&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Amenta EM, Spallone A, Rodriguez-Barradas MC, El Sahly HM, Atmar RL, Kulkarni PA. Postacute COVID-19: an overview and approach to classification. Open Forum Infect Dis. 2020;7:ofaa509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665635</ArticleId><ArticleId IdType="pubmed">33403218</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M, Schommers P, Stecher M, Dewald F, Gieselmann L, Gruell H, et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health &#x2013; Eur. 2021;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Khunti K, Nafilyan V, Maddox T, Humberstone B, Diamond I, et al. Post-COVID syndrome in individuals admitted to hospital with COVID-19: retrospective cohort study. BMJ. 2021;372:n693.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan M, Soddu D, Balbo PE, Baricich A, Zeppegno P, Avanzi GC, et al. Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge. JAMA Netw Open. 2021;4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7841464</ArticleId><ArticleId IdType="pubmed">33502487</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B, Mohn KG-I, Brokstad KA, Zhou F, Linchausen DW, Hansen B-A, et al. Long COVID in a prospective cohort of home-isolated patients. Nat Med. 2021 doi: 10.1038/s41591-021-01433-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouquegneau A, Huart J, Lutteri L, Erpicum P, Grosch S, R&#xe9;simont G, et al. Survivors of COVID-19 mostly recover from tubular proteinuria and acute kidney injury after hospital discharge. J Nephrol. 2021:1&#x2013;3. doi: 10.1007/s40620-021-01075-1. Epub ahead of print. PMID: 34089518; PMCID: PMC8179082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40620-021-01075-1</ArticleId><ArticleId IdType="pmc">PMC8179082</ArticleId><ArticleId IdType="pubmed">34089518</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke MJ, Rio C del. Long COVID has exposed medicine's blind-spot. Lancet Infect Dis. 2021 doi: 10.1016/S1473-3099(21)00333-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00333-9</ArticleId><ArticleId IdType="pmc">PMC8213360</ArticleId><ArticleId IdType="pubmed">34153235</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C, Laurent E, Lemaignen A, Beaufils E, Bourbao-Tournois C, Laribi S, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021;27:258&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan L, Chaudhary K, Saha A, Chauhan K, Vaid A, Zhao S, et al. AKI in hospitalized patients with COVID-19. J Am Soc Nephrol. 2021;32:151&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7894657</ArticleId><ArticleId IdType="pubmed">32883700</ArticleId></ArticleIdList></Reference><Reference><Citation>Charytan DM, Parnia S, Khatri M, Petrilli CM, Jones S, Benstein J, et al. Decreasing incidence of acute kidney injury in patients with COVID-19 critical illness in New York City. Kidney Int Rep. 2021;6:916&#x2013;927.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857986</ArticleId><ArticleId IdType="pubmed">33558853</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee A, Wu G, Primakov S, Oberije C, Woodruff H, Kubben P, et al. Can predicting COVID-19 mortality in a European cohort using only demographic and comorbidity data surpass age-based prediction: an externally validated study. PloS One. 2021;16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8049248</ArticleId><ArticleId IdType="pubmed">33857224</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97:829&#x2013;838.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7110296</ArticleId><ArticleId IdType="pubmed">32247631</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra V, Flanders SA, O'Malley M, Malani AN, Prescott HC. Sixty-day outcomes among patients hospitalized with COVID-19. Ann Intern Med. 2021;174:576&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference><Reference><Citation>Delanaye P, Huart J, Bouquegneau A, Jouret F. Long-term effects of COVID-19 on kidney function. Lancet. 2021;397:1807.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8118606</ArticleId><ArticleId IdType="pubmed">33992143</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang FC, Benson CA, del Rio C, Edwards KM, Fowler VG, Jr, Fredricks DN, et al. COVID-19 &#x2013; lessons learned and questions remaining. Clin Infect Dis. 2021;72:2225&#x2013;2240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7797746</ArticleId><ArticleId IdType="pubmed">33104186</ArticleId></ArticleIdList></Reference><Reference><Citation>Frix AN, Schoneveld L, Ladang A, Henket M, Duysinx B, Vaillant F, et al. Could KL-6 levels in COVID-19 help to predict lung disease? Respir Res. 2020;21:309.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7683867</ArticleId><ArticleId IdType="pubmed">33234132</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabarre P, Dumas G, Dupont T, Darmon M, Azoulay E, Zafrani L. Acute kidney injury in critically ill patients with COVID-19. Intensive Care Med. 2020;46:1339&#x2013;1348.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7290076</ArticleId><ArticleId IdType="pubmed">32533197</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E, Janvier P, Kherabi Y, Bot AL, Hamon A, Gouze H, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020;81:e4&#x2013;e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Guiot J, Vaidyanathan A, Deprez L, Zerka F, Danthine D, Frix A-N, et al. Development and validation of an automated radiomic CT signature for detecting COVID-19. Diagnostics (Basel) 2020;11(1):41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7823620</ArticleId><ArticleId IdType="pubmed">33396587</ArticleId></ArticleIdList></Reference><Reference><Citation>Guiot J, Danthine D, Deprez L, Louis R, Lovinfosse P, Meunier P. Chest radiological lesions in COVID-19&#xa0;: from classical imaging to artificial intelligence. Rev Med Liege Sup. 2020;75(Suppl. 1):81&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">33211427</ArticleId></ArticleIdList></Reference><Reference><Citation>Guiot J, Henket M, Frix AN, Delvaux M, Denis A, Giltay L, et al. Single-center experience of patients with interstitial lung diseases during the early days of the COVID-19 pandemic. Respir Investig. 2020;58(6):437&#x2013;439.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7501770</ArticleId><ArticleId IdType="pubmed">32978099</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26:1017&#x2013;1032.</Citation><ArticleIdList><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta S, Coca SG, Chan L, Melamed ML, Brenner SK, Hayek SS, et al. AKI treated with renal replacement therapy in critically ill patients with COVID-19. J Am Soc Nephrol. 2021;32:161&#x2013;176.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7894677</ArticleId><ArticleId IdType="pubmed">33067383</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirschtick JL, Titus AR, Slocum E, Power LE, Hirschtick RE, Elliott MR, et al. Population-based estimates of post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC) prevalence and characteristics. Clin Infect Dis. 2021 doi: 10.1093/cid/ciab408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab408</ArticleId><ArticleId IdType="pmc">PMC8240848</ArticleId><ArticleId IdType="pubmed">34007978</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Iadecola C, Anrather J, Kamel H. Effects of COVID-19 on the nervous system. Cell. 2020;183:16&#x2013;27. e1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7437501</ArticleId><ArticleId IdType="pubmed">32882182</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashif A, Chaudhry M, Fayyaz T, Abdullah M, Malik A, Anwer JMA, et al. Follow-up of COVID-19 recovered patients with mild disease. Sci Rep. 2021;11:13414.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8239036</ArticleId><ArticleId IdType="pubmed">34183705</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum JA, Lameire N, KDIGO AKI Guideline Work Group Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1) Crit Care. 2013;17:204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4057151</ArticleId><ArticleId IdType="pubmed">23394211</ArticleId></ArticleIdList></Reference><Reference><Citation>Laszlo G. Standardisation of lung function testing: helpful guidance from the ATS/ERS Task Force. Thorax. 2006;61:744&#x2013;746.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2117098</ArticleId><ArticleId IdType="pubmed">16936234</ArticleId></ArticleIdList></Reference><Reference><Citation>Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604&#x2013;612.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2763564</ArticleId><ArticleId IdType="pubmed">19414839</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Liu T, Yang N, Han D, Mi X, Li Y, et al. Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain. Front Med. 2020;14:533&#x2013;541.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7197033</ArticleId><ArticleId IdType="pubmed">32367431</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund LC, Hallas J, Nielsen H, Koch A, Mogensen SH, Brun NC, et al. Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study. Lancet Infect Dis. 2021 doi: 10.1016/S1473-3099(21)00211-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00211-5</ArticleId><ArticleId IdType="pmc">PMC8110209</ArticleId><ArticleId IdType="pubmed">33984263</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence  . NICE; London: 2020. Overview. COVID-19 rapid guideline: managing the long-term effects of COVID-19.https://www.nice.org.uk/guidance/ng188 Available at. accessed 2 April 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Nauen DW, Hooper JE, Stewart CM, Solomon IH. Assessing brain capillaries in coronavirus disease 2019. JAMA Neurol. 2021;78:760&#x2013;762.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7881367</ArticleId><ArticleId IdType="pubmed">33576767</ArticleId></ArticleIdList></Reference><Reference><Citation>Radermecker C, Detrembleur N, Guiot J, Cavalier E, Henket M, d'Emal C, et al. Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19. J Exp Med. 2020;217(12):e20201012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7488867</ArticleId><ArticleId IdType="pubmed">32926097</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronco C, Reis T, Husain-Syed F. Management of acute kidney injury in patients with COVID-19. Lancet Respir Med. 2020;8:738&#x2013;742.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7255232</ArticleId><ArticleId IdType="pubmed">32416769</ArticleId></ArticleIdList></Reference><Reference><Citation>Salamanna F, Veronesi F, Martini L, Landini MP, Fini M. Post-COVID-19 syndrome: the persistent symptoms at the post-viral stage of the disease. A systematic review of the current data. Front Med (Lausanne) 2021;8:653516. https://www.frontiersin.org/articles/10.3389/fmed.2021.653516/full Available at. accessed 1 July 2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.653516/full</ArticleId><ArticleId IdType="pmc">PMC8129035</ArticleId><ArticleId IdType="pubmed">34017846</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoneveld L, Ladang A, Henket M, Frix A-N, Cavalier E, Guiot J, et al. YKL-40 as a new promising prognostic marker of severity in COVID infection. Crit Care. 2021;25:66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7886185</ArticleId><ArticleId IdType="pubmed">33593373</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran V-T, Riveros C, Clepier B, Desvarieux M, Collet C, Yordanov Y, et al. Development and validation of the long COVID symptom and impact tools, a set of patient-reported instruments constructed from patients&#x2019; lived experience. Clin Infect Dis. 2021 doi: 10.1093/cid/ciab352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab352</ArticleId><ArticleId IdType="pmc">PMC8135558</ArticleId><ArticleId IdType="pubmed">33912905</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu G, Yang P, Xie Y, Woodruff HC, Rao X, Guiot J, et al. Development of a clinical decision support system for severity risk prediction and triage of COVID-19 patients at hospital admission: an international multicentre study. Eur Respir J. 2020;56(2):2001104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7331655</ArticleId><ArticleId IdType="pubmed">32616597</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>